Haploidentical hematopoietic stem cell transplantation using post-transplant cyclophosphamide in patients with inborn errors of immunity: Experience in a reference center in Colombia
Haploidentical hematopoietic stem cell transplantation using post-transplant cyclophosphamide is a viable alternative for inborn errors of immunity when an identical donor is unavailable. Serial chimerism monitoring is useful for graft follow-up.
Authors
- D. Castro (ORCID: https://orcid.org/0000-0001-9177-3698)
- Diego Medina (ORCID: https://orcid.org/0000-0002-1465-7957)
- Estefanía Beltrán (ORCID: https://orcid.org/0000-0003-2438-8356)
- Alexis A. Franco (ORCID: https://orcid.org/0000-0002-3173-6059)
- Manuela Olaya (ORCID: https://orcid.org/0000-0002-3239-8928)
- Eliana Manzi (ORCID: https://orcid.org/0000-0001-5577-970X)
- J. E. Castro (ORCID: https://orcid.org/0000-0002-8155-5985)
Institutions
- Fundación Valle del Lili (CO)
- Icesi University (CO)
Publication Details
- Journal
- Biomédica
- Published
- 2024-12-23
- DOI
- https://doi.org/10.7705/biomedica.7560
- Citations
- 1
- Primary Topic
- Immunodeficiency and Autoimmune Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.24